Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment

Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment

<i>Background and Objectives</i>: Brolucizumab (IVBr) is a recently introduced anti-vascular endothelial growth factor (anti-VEGF) which has been found to be very effective in treating neovascular age-related macular degeneration (nAMD). We reported our findings in a case of nAMD that de...

Full description

Bibliographic Details
Main Authors: Natsuki Ueji, Yoko Mase, Akiko Kubo, Hisashi Matsubara, Shinichiro Chujo, Yoshitsugu Matsui, Mineo Kondo
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Medicina
Subjects:
age-related macular degeneration
AMD
intraocular inflammation
IOI
brolucizumab
dementia
Online Access:https://www.mdpi.com/1648-9144/59/10/1856

Internet

https://www.mdpi.com/1648-9144/59/10/1856

Similar Items